A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfacytine
5-(2-methylpiperazine-1-sulfonyl)isoquinoline
The therapeutic efficacy of Canagliflozin can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.
Sulfacytine
Sulfameter
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfameter.
Sulfacytine
Sulfaphenazole
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaphenazole.
Sulfacytine
Sulfadimethoxine
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadimethoxine.
Sulfacytine
Hydroxyfasudil
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Hydroxyfasudil.
Sulfacytine
Sulfamethazine
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamethazine.
Sulfacytine
Sulfamerazine
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamerazine.
Sulfacytine
Sulfadoxine
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadoxine.
Sulfacytine
Sulfacytine
The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfacytine.
Sulfacytine
Sulfate ion
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sulfate ion.
Sulfacytine
Glycerin
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Glycerin.
Sulfacytine
Polyethylene glycol
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Polyethylene glycol.
Sulfacytine
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Dehydrocholic acid.
Sulfacytine
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Frangula purshiana bark.
Sulfacytine
Alloin
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Alloin.
Sulfacytine
Konjac mannan
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Konjac mannan.
Sulfacytine
Calcium polycarbophil
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Calcium polycarbophil.
Sulfacytine
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Oxyphenisatin acetate.
Sulfacytine
Plantago ovata seed
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Plantago ovata seed.
Sulfacytine
Sodium cation
The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium cation.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3